Cell fusion induced by lysolecithin and concanavalin A in Drosophila melanogaster somatic cells cultured in vitro

1976 ◽  
Vol 100 (2) ◽  
pp. 399-404 ◽  
Author(s):  
Carlotta Halfer ◽  
Lucia Petrella
Genetics ◽  
1990 ◽  
Vol 124 (2) ◽  
pp. 331-337 ◽  
Author(s):  
J A Sved ◽  
W B Eggleston ◽  
W R Engels

Abstract The P element insertion delta 2-3(99B) has previously been shown to activate incomplete P elements elsewhere in the genome. We show that this element, in conjunction with a second incomplete P element, P[CaSpeR], also induces recombination in the male germ line. The recombination is induced preferentially in the region of the P[CaSpeR] element. Recombinant chromosomes contain the P[CaSpeR] element in more than 50% of cases, and alternative models of transposon replication and preferential chromosome breakage are put forward to explain this finding. As is the case with male recombination induced by P-M dysgenic crosses, recombination appears to be premeiotic in a high proportion of cases. The delta 2-3(99B) element is known to act in somatic cells. Correspondingly, we show that the delta 2-3(99B)-P[CaSpeR] combination elevates the incidence of somatic recombination.


Chromosoma ◽  
1977 ◽  
Vol 59 (3) ◽  
pp. 259-272 ◽  
Author(s):  
E. V. Ananiev ◽  
L. G. Polukarova ◽  
Y. B. Yurov

Cells ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 490
Author(s):  
Krystyna Żyżyńska-Galeńska ◽  
Agnieszka Bernat ◽  
Anna Piliszek ◽  
Jolanta Karasiewicz ◽  
Ewa Szablisty ◽  
...  

The phenomenon of the reprogramming of terminally differentiated cells can be achieved by various means, like somatic cell nuclear transfer, cell fusion with a pluripotent cell, or the introduction of pluripotency genes. Here, we present the evidence that somatic cells can attain the expression of pluripotency markers after their introduction into early embryos. Mouse embryonic fibroblasts introduced between blastomeres of cleaving embryos, within two days of in vitro culture, express transcription factors specific to blastocyst lineages, including pluripotency factors. Analysis of donor tissue marker DNA has revealed that the progeny of introduced cells are found in somatic tissues of foetuses and adult chimaeras, providing evidence for cell reprogramming. Analysis of ploidy has shown that in the chimaeras, the progeny of introduced cells are either diploid or tetraploid, the latter indicating cell fusion. The presence of donor DNA in diploid cells from chimaeric embryos proved that the non-fused progeny of introduced fibroblasts persisted in chimaeras, which is evidence of reprogramming by embryonic niche. When adult somatic (cumulus) cells were introduced into early cleavage embryos, the extent of integration was limited and only cell fusion-mediated reprogramming was observed. These results show that both cell fusion and cell interactions with the embryonic niche reprogrammed somatic cells towards pluripotency.


Chromosoma ◽  
1964 ◽  
Vol 15 (3) ◽  
pp. 301-311 ◽  
Author(s):  
Marco Crippa
Keyword(s):  

1993 ◽  
Vol 69 (04) ◽  
pp. 335-338 ◽  
Author(s):  
Marisa Zucchella ◽  
Lucia Pacchiarini ◽  
Fiorenzo Tacconi ◽  
Anna Saporiti ◽  
Guido Grignani

SummaryWe studied in a homologous system the procoagulant activity of human tumor cells cultured “in vitro” (1402 primary melanoma, Me 7110/2 metastatic melanoma, Hep G2 hepatoma and GLC1 small cell lung carcinoma) or of cells freshly isolatedfrom different human tumor tissues.Tumor cells cultured “in vitro” possessed and released a factor VII dependent procoagulant activity, which was inhibitedby concanavalin A and unaffected by iodoacetamide or HgCl2. The activity released by the cells of metastatic melanoma was higher than that released by the cells of the primary tumor. On the contrary, cancer cells isolated from tumor tissues possessed and released a factor VII independent activity which was inhibited by iodoacetamide or HgCl2 and was not modified by concanavalin A. Therefore, different methods for the preparation of tumor cell suspensions have to be used for the study of tumor procoagulants, since their expression depends very largely on the source of tumor cells. Furthermore, cultured human tumor cells are not an appropriate model for the “in vivo” procoagulant effect of tumor cells.


2012 ◽  
Vol 2012 ◽  
pp. 1-13 ◽  
Author(s):  
Nicholas A. Kouris ◽  
Jeremy A. Schaefer ◽  
Masato Hatta ◽  
Brian T. Freeman ◽  
Timothy J. Kamp ◽  
...  

Mesenchymal stem cells (MSCs) spontaneously fuse with somatic cellsin vivo, albeit rarely, and the fusion products are capable of tissue-specific function (mature trait) or proliferation (immature trait), depending on the microenvironment. That stem cells can be programmed, or somatic cells reprogrammed, in this fashion suggests that stem cell fusion holds promise as a therapeutic approach for the repair of damaged tissues, especially tissues not readily capable of functional regeneration, such as the myocardium. In an attempt to increase the frequency of stem cell fusion and, in so doing, increase the potential for cardiac tissue repair, we expressed the fusogen of the vesicular stomatitis virus (VSV-G) in human MSCs. We found VSV-G expressing MSCs (vMSCs) fused with cardiomyocytes (CMs) and these fusion products adopted a CM-like phenotype and morphologyin vitro.In vivo, vMSCs delivered to damaged mouse myocardium via a collagen patch were able to home to the myocardium and fuse to cells within the infarct and peri-infarct region of the myocardium. This study provides a basis for the investigation of the biological impact of fusion of stem cells with CMsin vivoand illustrates how viral fusion proteins might better enable such studies.


2011 ◽  
Vol 13 (4) ◽  
pp. 331-344 ◽  
Author(s):  
Pollyanna Agnes Tat ◽  
Huseyin Sumer ◽  
Daniele Pralong ◽  
Paul John Verma

Planta Medica ◽  
2014 ◽  
Vol 80 (16) ◽  
Author(s):  
R Paduch ◽  
M Tomczyk ◽  
A Wiater ◽  
A Dudek ◽  
M Pleszczynska ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document